Yamamoto H, Swoger J, Greene S, Saito T, Hurh J, Sweeley C, Leestma J, Mkrdichian E, Cerullo L, Nishikawa A, Ihara Y, Taniguchi N, Moskal J R
The Chicago Institute of Neurosurgery and Neuroresearch, Illinois 60614, USA.
Cancer Res. 2000 Jan 1;60(1):134-42.
The metastatic potential of tumor cells has been shown to be correlated with the expression of tri- and tetra-antennary beta1,6-N-acetylglucosamine (beta1,6-GlcNAc)-bearing N-glycans, which are recognized by Phaseolus vulgaris leukoagglutinating lectin (L-PHA). The expression of beta1,6-GlcNAc-bearing N-glycans also has been used as a marker of tumor progression in human breast and colon cancers. In this report, the role of N-glycan branching in regulating glioma migration and invasion was examined. The expression of beta1,6-GlcNAc-bearing N-glycans was found in human glioma specimens, whereas astrocytes from normal adult brain were negative. The expression of N-acetylglucosaminyltransferase V (GnT-V) mRNA, which is responsible for the biosynthesis of beta1,6-GlcNAc-bearing N-glycans, was high in glioma cell lines with robust ets-1 expression. To study the molecular mechanism of GnT-V expression in human glioma cells, an inducible ets-1 gene was stably transfected into SNB-19 cells using a tetracycline repressor system. GnT-V mRNA expression was increased by the induction of c-ets-1, suggesting that the Ets-1 transcription factor directly regulates the transcription of GnT-V. Stable transfection of GnT-V into human glioma U-373 MG cells resulted in changes in cell morphology and focal adhesions and a marked increase in glioma invasivity in vitro. L-PHA has little effect on cell migration. On the contrary, Phaseolus vulgaris erythroagglutinating lectin (E-PHA), which recognizes bisecting beta1,4-GlcNAc-bearing N-glycans, strongly inhibits cell migration (haptotaxis) on a fibronectin substrate in U-373 MG transfectants and other glioma cell lines tested. These results suggest that the increased beta1,6-GlcNAc-bearing N-glycan expression found in malignant gliomas is modulated by GnT-V through the Ets-1 transcription factor, and that the branching of complex type N-glycans plays a major role in glioma invasivity.
肿瘤细胞的转移潜能已被证明与带有三天线和四天线β1,6-N-乙酰葡糖胺(β1,6-GlcNAc)的N-聚糖的表达相关,这些N-聚糖可被菜豆白细胞凝集素(L-PHA)识别。带有β1,6-GlcNAc的N-聚糖的表达也已被用作人类乳腺癌和结肠癌肿瘤进展的标志物。在本报告中,研究了N-聚糖分支在调节胶质瘤迁移和侵袭中的作用。在人类胶质瘤标本中发现了带有β1,6-GlcNAc的N-聚糖的表达,而来自正常成人大脑的星形胶质细胞呈阴性。负责带有β1,6-GlcNAc的N-聚糖生物合成的N-乙酰葡糖胺基转移酶V(GnT-V)mRNA在具有强大ets-1表达的胶质瘤细胞系中表达较高。为了研究人类胶质瘤细胞中GnT-V表达的分子机制,使用四环素阻遏系统将可诱导的ets-1基因稳定转染到SNB-19细胞中。c-ets-1的诱导增加了GnT-V mRNA的表达,表明Ets-1转录因子直接调节GnT-V的转录。将GnT-V稳定转染到人类胶质瘤U-373 MG细胞中导致细胞形态和粘着斑发生变化,并在体外显著增加了胶质瘤的侵袭性。L-PHA对细胞迁移影响很小。相反,识别带有平分型β1,4-GlcNAc的N-聚糖的菜豆红细胞凝集素(E-PHA)强烈抑制U-373 MG转染细胞和其他测试的胶质瘤细胞系在纤连蛋白底物上的细胞迁移(趋触性)。这些结果表明,恶性胶质瘤中发现的带有β1,6-GlcNAc的N-聚糖表达增加是由GnT-V通过Ets-1转录因子调节的,并且复杂型N-聚糖的分支在胶质瘤侵袭中起主要作用。